| dc.contributor.author | Andrés Rodríguez, Laura | |
| dc.contributor.author | Feliu-Soler, Albert | |
| dc.contributor.author | Borràs, Xavier | |
| dc.contributor.author | Feliu-Soler, Albert | |
| dc.contributor.author | Pérez-Aranda, Adrián | |
| dc.contributor.author | Rozadilla, Antonio | |
| dc.contributor.author | Arranz, Belén | |
| dc.contributor.author | Montero-Marin, Jesús | |
| dc.contributor.author | Garcia-Campayo, Javier | |
| dc.contributor.author | Angarita-Osorio, Natalia | |
| dc.contributor.author | Maes, Michael | |
| dc.contributor.author | Luciano, Juan V. | |
| dc.date.accessioned | 2022-01-25T15:15:35Z | |
| dc.date.available | 2022-01-25T15:15:35Z | |
| dc.date.issued | 2019 | |
| dc.identifier.citation | Andrés-Rodríguez, Laura; Albert, Feliu-Soler; Borràs, Xavier [et al.]. Machine learning to understand the immune-inflammatory pathways in fibromyalgia. International Journal of Molecular Sciences, 2019, 20(17), 4231. Disponible en: <https://www.mdpi.com/1422-0067/20/17/4231>. Fecha de acceso: 25 ene. 2022. DOI: 10.3390/ijms20174231 | ca |
| dc.identifier.issn | 1422-0067 | ca |
| dc.identifier.uri | http://hdl.handle.net/20.500.12328/3097 | |
| dc.description | The study has been funded in part by the Instituto de Salud Carlos III (ISCIII) of the Ministry of Economy and Competitiveness (Spain) through the Network for Prevention and Health Promotion in Primary Care (RD16/0007/0005 & RD16/0007/0012), by a grant for research projects on health from ISCIII (PI15/00383) cofinanced with European Union ERDF funds. The first listed author has a FI predoctoral contract awarded by the Agency for Management of University and Research Grants (AGAUR; 2018; FI_B00783). The third listed author has a “Sara Borrell” research contract from the ISCIII (CD16/00147). The fourth listed author has a FI predoctoral contract awarded by the Agency for Management of University and Research Grants (AGAUR; 2017; FI_B00754). The last listed author (JVL) has a “Miguel Servet” research contract from the ISCIII CP14/00087). This study was awarded both with the Grant PSSJD & FSJD 2016 and with the I Premio del Instituto esMindfulness 2016 (www.esmindfulness.com), to whom we are truly thankful. | en |
| dc.description.abstract | Fibromyalgia (FM) is a chronic syndrome characterized by widespread musculoskeletal pain, and physical and emotional symptoms. Although its pathophysiology is largely unknown, immune-inflammatory pathways may be involved. We examined serum interleukin (IL)-6, high sensitivity C-reactive protein (hs-CRP), CXCL-8, and IL-10 in 67 female FM patients and 35 healthy women while adjusting for age, body mass index (BMI), and comorbid disorders. We scored the Fibromyalgia Severity Score, Widespread Pain Index (WPI), Symptom Severity Scale (SSS), Hospital Anxiety (HADS-A), and Depression Scale and the Perceived Stress Scale (PSS-10). Clinical rating scales were significantly higher in FM patients than in controls. After adjusting for covariates, IL-6, IL-10, and CXCL-8 were lower in FM than in HC, whereas hs-CRP did not show any difference. Binary regression analyses showed that the diagnosis FM was associated with lowered IL-10, quality of sleep, aerobic activities, and increased HADS-A and comorbidities. Neural networks showed that WPI was best predicted by quality of sleep, PSS-10, HADS-A, and the cytokines, while SSS was best predicted by PSS-10, HADS-A, and IL-10. Lowered levels of cytokines are associated with FM independently from confounders. Lowered IL-6 and IL-10 signaling may play a role in the pathophysiology of FM. | en |
| dc.format.extent | 16 | ca |
| dc.language.iso | eng | ca |
| dc.publisher | MDPI | ca |
| dc.relation.ispartof | International Journal of Molecular Sciences | ca |
| dc.relation.ispartofseries | 20;17 | |
| dc.rights | This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | en |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject.other | Fibromiàlgia | ca |
| dc.subject.other | Dolor generalitzat | ca |
| dc.subject.other | Citocines | ca |
| dc.subject.other | Inflamació | ca |
| dc.subject.other | Neuroimmune | ca |
| dc.subject.other | Fibromialgia | es |
| dc.subject.other | Dolor generalizado | es |
| dc.subject.other | Citocinas | es |
| dc.subject.other | Inflamación | es |
| dc.subject.other | Neuroinmune | en |
| dc.subject.other | Fibromyalgia | en |
| dc.subject.other | Widespread pain | en |
| dc.subject.other | Cytokines | en |
| dc.subject.other | Inflammation | en |
| dc.subject.other | Neuro-immune | en |
| dc.title | Machine learning to understand the immune-inflammatory pathways in fibromyalgia | en |
| dc.type | info:eu-repo/semantics/article | ca |
| dc.description.version | info:eu-repo/semantics/publishedVersion | ca |
| dc.rights.accessLevel | info:eu-repo/semantics/openAccess | |
| dc.embargo.terms | cap | ca |
| dc.subject.udc | 61 | ca |
| dc.subject.udc | 616.8 | ca |
| dc.identifier.doi | https://dx.doi.org/10.3390/ijms20174231 | ca |